Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chinghai Kao

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2007
Advances in preclinical investigation of prostate cancer gene therapyMarxa L Figueiredo, Chinghai Kao, Lily Wu
The Urologic Clinics of North America|April 25, 2006
Future innovations in treating advanced prostate cancerPratik Desai, Juan A Jiménez, Chinghai Kao, et al.
Cancer Metastasis Reviews|December 6, 2002
Prostate cancer gene therapy: past experiences and future promiseThomas A Gardner, James Sloan, Sudhanshu P Raikwar, et al.
Urologic Oncology|May 9, 2006
Current status of anti-angiogenesis therapy for prostate cancerJuan Antonio Jiménez, Chinghai Kao, Sudhanshu Raikwar, et al.
Bone|October 14, 2003
Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell culturesXudong Li, Quanjun Cui, Chinghai Kao, et al.
Cancer Research|September 22, 2011
Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancerZiyue Karen Jiang, Makoto Sato, Liu H Wei, et al.
The Journal of Urology|December 18, 2007
Anti-angiogenic gene therapy for metastatic renal cell carcinoma produces tumor growth suppression in an athymic nude mouse modelMatthew J Mellon, Miwon Ahn, Juan A Jiménez, et al.
The Journal of Gene Medicine|June 8, 2010
Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distributionXiong Li, Youhong Liu, Yong Tang, et al.
IEEE Transactions on Bio-Medical Engineering|August 10, 2011
An ultrasonically powered implantable micro-oxygen generator (IMOG)Teimour Maleki, Ning Cao, Seung Hyun Song, et al.
The Journal of Biological Chemistry|March 20, 2004
Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activationYing Liu, Byung Oh Kim, Chinghai Kao, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2007
Advances in preclinical investigation of prostate cancer gene therapyMarxa L Figueiredo, Chinghai Kao, Lily Wu
The Urologic Clinics of North America|April 25, 2006
Future innovations in treating advanced prostate cancerPratik Desai, Juan A Jiménez, Chinghai Kao, et al.
Cancer Metastasis Reviews|December 6, 2002
Prostate cancer gene therapy: past experiences and future promiseThomas A Gardner, James Sloan, Sudhanshu P Raikwar, et al.
Urologic Oncology|May 9, 2006
Current status of anti-angiogenesis therapy for prostate cancerJuan Antonio Jiménez, Chinghai Kao, Sudhanshu Raikwar, et al.
Bone|October 14, 2003
Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell culturesXudong Li, Quanjun Cui, Chinghai Kao, et al.
Cancer Research|September 22, 2011
Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancerZiyue Karen Jiang, Makoto Sato, Liu H Wei, et al.
The Journal of Urology|December 18, 2007
Anti-angiogenic gene therapy for metastatic renal cell carcinoma produces tumor growth suppression in an athymic nude mouse modelMatthew J Mellon, Miwon Ahn, Juan A Jiménez, et al.
The Journal of Gene Medicine|June 8, 2010
Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distributionXiong Li, Youhong Liu, Yong Tang, et al.
IEEE Transactions on Bio-Medical Engineering|August 10, 2011
An ultrasonically powered implantable micro-oxygen generator (IMOG)Teimour Maleki, Ning Cao, Seung Hyun Song, et al.
The Journal of Biological Chemistry|March 20, 2004
Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activationYing Liu, Byung Oh Kim, Chinghai Kao, et al.
Pageof 5